Scandinavian ChemoTech AB (publ) Interim report Q2 January – June 2022 - Executive Summary
Second quarter · Net sales amounted to kSEK 72 (5) · Profit before tax amounted to kSEK -5 962 (-3 796 · Earnings per share amounted to SEK -0,62 (-0,44) · Cash flow from operating activities totaled to kSEK -4 340 (-850) Period 1 January - 30 June · Net sales amounted to kSEK 127 (30) · Profit before tax amounted to kSEK -10 676 (-6 581) · Earnings per share amounted to SEK -1,11 (-0,81) · Cash flow from operating activities totaled to kSEK -9 135 (-6 414) · The order book amounted to kSEK 1 060 (1 122), at the end of the period Important events during